Hyman SE. A New Hope for Biological Insights Into Depression. Biol Psychiatry. 2017;81(4):280-281. doi:10.1016/j.biopsych.2016.12.001
Bargiela D, Bianchi MT, Westover B, et al. Selection of first-line therapy in multiple sclerosis using risk-benefit decision analysis. Neurology. 2017;88(7):677-684. doi:10.1212/WNL.0000000000003612
Charney AW, Ruderfer DM, Stahl EA, et al. Evidence for genetic heterogeneity between clinical subtypes of bipolar disorder. Transl Psychiatry. 2017;7(1):e993. doi:10.1038/tp.2016.242
St Pourcain B, Robinson EB, Anttila V, et al. ASD and schizophrenia show distinct developmental profiles in common genetic overlap with population-based social communication difficulties. Mol Psychiatry. 2018;23(2):263-270. doi:10.1038/mp.2016.198
Winkler EA, Yue JK, Ferguson AR, et al. COMT Val(158)Met polymorphism is associated with post-traumatic stress disorder and functional outcome following mild traumatic brain injury. J Clin Neurosci. 2017;35:109-116. doi:10.1016/j.jocn.2016.09.017
Bajorath J, Peltason L, Wawer M, Guha R, Lajiness MS, Van Drie JH. Navigating structure-activity landscapes. Drug Discov Today. 2009;14(13-14):698-705. doi:10.1016/j.drudis.2009.04.003
Wawer M, Bajorath J. Extraction of structure-activity relationship information from high-throughput screening data. Curr Med Chem. 2009;16(31):4049-57.
DeRan M, Pulvino M, Zhao J. Assessing G1-to-S-phase progression after genotoxic stress. Methods Mol Biol. 2011;782:221-30. doi:10.1007/978-1-61779-273-1_16
DeRan M, Pulvino M, Greene E, Su C, Zhao J. Transcriptional activation of histone genes requires NPAT-dependent recruitment of TRRAP-Tip60 complex to histone promoters during the G1/S phase transition. Mol Cell Biol. 2008;28(1):435-47. doi:10.1128/MCB.00607-07
Carmody LC, Germain AR, VerPlank L, et al. Phenotypic high-throughput screening elucidates target pathway in breast cancer stem cell-like cells. J Biomol Screen. 2012;17(9):1204-10. doi:10.1177/1087057112458317